AT1-receptor blockade, but not renin inhibition, reduces aneurysm growth and cardiac failure in fibulin-4 mice-Reference-Cited by-同舟云学术

AT1-receptor blockade, but not renin inhibition, reduces aneurysm growth and cardiac failure in fibulin-4 mice

Published:2016-04 Issue:4 Volume:34 Page:654-665
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

te Riet Luuk,van Deel Elza D.,van Thiel Bibi S.,Moltzer Els,van Vliet Nicole,Ridwan Yanto,van Veghel Richard,van Heijningen Paula M.,Robertus Jan Lukas,Garrelds Ingrid M.,Vermeij Marcel,van der Pluijm Ingrid,Danser A.H. Jan,Essers Jeroen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference56 articles.

1. Thoracic and abdominal aortic aneurysms.;Isselbacher;Circulation,2005

2. Marfan-syndrome caused by a recurrent denovo missense mutation in the fibrillin gene.;Dietz;Nature,1991

3. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.;Judge;J Clin Invest,2004

4. Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase.;Horiguchi;Proc Natl Acad Sci U S A,2009

5. Fibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies.;Papke;Matrix Biol,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling;Biochemical Pharmacology;2024-04

2. The Angiotensin AT₂Receptor: From a Binding Site to a Novel Therapeutic Target;Pharmacological Reviews;2022-09-30

3. Matricellular proteins: Potential biomarkers and mechanistic factors in aortic aneurysms;Journal of Molecular and Cellular Cardiology;2022-08

4. Genetic and clinical determinants of abdominal aortic diameter: genome-wide association studies, exome array data and Mendelian randomization study;Human Molecular Genetics;2022-03-02

5. Captopril versus atenolol to prevent expansion rate of thoracic aortic aneurysms: rationale and design;Future Cardiology;2021-03